Accueil > Actualité
Actualite financiere : Actualite bourse

Sanofi: high-dose Fluzone vaccine approved

( - Sanofi has announced that the US FDA has a supplemental Biologics License Application for Fluzone High-Dose Quadrivalent (Influenza Vaccine) for use in adults 65 years of age and older.

This version will be available for the immunization efforts during the 2020-2021 flu vaccination campaign. Sanofi Pasteur will continue to produce and distribute the trivalent version until the end of the 2019-2020 flu season.

At the end of the 2018-2019 season, over 112 million doses of high-dose Fluzone had been distributed to the United States. During the season, nearly two thirds of the over-65s vaccinated against flu in the US received high-dose Fluzone.

Copyright (c) 2019 All rights reserved.




Qui sommes-nous ? | Nous contacter | FAQ | Mentions légales | RSS | © Copyright 2007 Cercle Finance. Tous droits réservés.
Indices et cours différés d’au moins 15 mn | Cotations boursières fournies par ABC Bourse.